Author:
Yao Cheng-cai,Liu Changchun,Xian Jiayi
Abstract
Abstract
Background
This study aimed to compare the effects of single-pore non-liposuction near-infrared (NIR) endoscopic surgery and traditional open surgery for axillary sentinel lymph node biopsy (SLNB) in patients with early breast cancer (EBC).
Methods
The clinical pathological data of 61 patients with EBC who underwent axillary SLNB using indocyanine green (ICG) combined with carbon nanoparticle suspension (CNS) were retrospectively collected. Thirty patients received SLNB through single-pore non-liposuction NIR endoscopic surgery (endoscopic group), and the remaining 31 received SLNB through open-incision surgery (open group). The success rate, operation time, volume of intraoperative bleeding, postoperative axillary drainage, axillary extubation time, and the occurrence of postoperative complications were compared between the groups along with the total number of sentinel lymph nodes (SLNs), luminous SLNs, stained SLNs, and the pathological positivity rate of the SLNs.
Results
All patients underwent SLNB with a 100% success rate. SLNB operation times of the endoscopic group were longer than those of the open group (t = 3.963, P = 0.000), and the volume of axillary drainage was inferior (t = 3.035, P = 0.004). However, there were no differences in the intraoperative bleeding volumes, axillary extubation times, and postoperative complications (P > 0.05). In the Open group, the mean number of SLNs was 5.12 ± 2.16, and the pathological positivity rate was 13.53%; in the Endoscopic group, these numbers were 4.89 ± 1.73 and 12.39%. The mean number of SLNs detected (t = 0.458, P = 0.649) and the pathological positivity rates (χ2 = 0.058, P = 0.810) did not differ between the two groups. All 61 patients were followed for a median of 14.6 months. There were no local recurrences or distant metastases.
Conclusions
Our single-center results reveal that single-hole non-liposuction NIR endoscopic axillary SLNB is not inferior to open SLNB and may be an appropriate option for patients with early breast cancer who desire breast preservation with fewer incisions.
Trial registration
This retrospective study was “retrospectively registered” at the Sixth Affiliated Hospital of South China University of Technology (no. 2020105) and in National Medical Research Registration and Archival Information System (https://www.medicalresearch.org.cn, number: MR-44-21-004727).
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Luo CY, Zhang J, Lin H, et al. Mastoscopic axillary lymph node dissection for the patients with breast cancer. Zhonghua Yi Xue Za Zhi. 2003;83:1946–8.
2. Guo MQ, Jiang J, Yang XH, et al. Technique investigation of endoscopic axillary lymph node dissection by liposuction. Zhonghua Wai Ke Za Zhi. 2006;44:757–61.
3. Shi F, Huang Z, Yu J, et al. Immediate liposuction could shorten the time for endoscopic axillary lymphadenectomy in breast cancer patients. World J Surg Oncol. 2017;15:35–41.
4. Chengyu L, Yongqiao Z, Hua L, et al. A standardized surgical technique for mastoscopic axillary lymph node dissection. Surg Laparosc Endosc Percutan Tech. 2005;15:153–9.
5. Bonin EA, Mariani A, Swain J, et al. Laparoscopic ultrasound-assisted liposuction for lymph node dissection: a pilot study. Surg Endosc. 2012;26:1963–70.